IMBLN Competition

Bonds . USA . 
Bond . IMBLN 35 26 JUL 26
45262BAB9   94.18  3.35  3.43%   
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
93.4594.1894.91
Details
Intrinsic
Valuation
LowRealHigh
84.7785.50103.60
Details
Naive
Forecast
LowNextHigh
91.9292.6593.38
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
93.2193.9394.64
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as IMBLN. Your research has to be compared to or analyzed against IMBLN's peers to derive any actionable benefits. When done correctly, IMBLN's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in IMBLN 35 26.

IMBLN Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between IMBLN and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of IMBLN and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of IMBLN 35 26 does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CELH
+ 0.8
WVVI
DLPN
+ 0.71
WVVI
DLPN
+ 0.6
CELH
WIMI
+ 0.45
ABEV
DLPN
+ 0.43
ABEV
WVVI
+ 0.41
ABEV
  
High negative correlations   
FLNT
- 0.38
WVVI
DLPN
- 0.36
FLNT
FLNT
- 0.34
CELH
WIMI
- 0.22
STGW
DLPN
- 0.21
STGW
CELH
- 0.21
STGW

Risk-Adjusted Indicators

There is a big difference between IMBLN Bond performing well and IMBLN Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IMBLN's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

IMBLN Competitive Analysis

The better you understand IMBLN competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, IMBLN's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across IMBLN's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
45262BAB9 STGW ABEV WVVI OGSM WIMI CELH FLNT DLPN
 3.43 
 94.18 
IMBLN
 0.51 
 7.82 
Stagwell
 1.86 
 2.19 
Ambev
 1.49 
 3.31 
Willamette
 0.00 
 0.0001 
Organic
 7.69 
 0.84 
WiMi
 0.90 
 29.31 
Celsius
 0.35 
 2.81 
Fluent
 0.93 
 1.07 
Dolphin
Market Volatility
(90 Days Market Risk)
Very steady
Somewhat reliable
Slightly risky
Slightly risky
Very steady
Very risky
Very steady
Very risky
Very risky
Market Performance
(90 Days Performance)
Very Weak
Modest
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
About Average
Below Average
Low
Below Average
Very High
High
Very Small
Quite High
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Strong Sell
Not Available
Strong Sell
Strong Buy
Hold
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Sell
Current Ratio
N/A
0.88
1.19
3.99
0.17
6.51
2.87
1.79
1.24
Net Asset
N/A
3.77 B
132.64 B
105.71 M
180.81 K
1.03 B
1.54 B
111.87 M
94.19 M
Profit Margin
N/A
1.0E-4
0.17
-0.0226
-1.46
-0.67
0.16
-0.2
-0.32
EBITDA
N/A
324.54 M
23.46 B
2.33 M
(582.44 K)
(509.6 M)
266.37 M
(49.25 M)
(17.86 M)
Operating Margin
N/A
0.0595
0.24
0.052
-1.47
-0.0115
-0.0121
-0.12
-0.0811
Current Valuation
N/A
2.5 B
31.27 B
88 M
1.19 M
(55.73 M)
6.82 B
81.15 M
31.62 M
Price To Book
N/A
3.05
2.04
0.63
N/A
0.79
16.26
2.37
0.88
Retained Earnings
N/A
21.15 M
43.19 B
19.73 M
(7.83 M)
(940.33 M)
(12.05 M)
(381.52 M)
(133.61 M)
Current Asset
N/A
N/A
28.31 B
9.05 M
223 K
N/A
14.08 M
28.61 M
8.32 M
Five Year Return
N/A
N/A
2.97
N/A
N/A
N/A
N/A
N/A
N/A
Beta
N/A
1.61
0.55
0.75
-0.73
1.27
1.85
2.29
1.96
Number Of Employees
N/A
10.25 K
43 K
223
5
107
765
274
245
Shares Outstanding
N/A
111.55 M
15.73 B
4.96 M
13.86 M
88.15 M
235.03 M
16.88 M
11.16 M
Cash Flow From Operations
N/A
81.01 M
24.71 B
(1.99 M)
(394.61 K)
88.56 M
141.22 M
8.14 M
(4.62 M)
Annual Yield
N/A
N/A
0.068
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
N/A
1.49 B
3.5 B
23.52 M
N/A
49.92 M
2.19 M
34.48 M
25.59 M
Return On Equity
N/A
0.0728
0.15
-0.0126
N/A
-0.47
0.19
-1.12
-0.66
Z Score
N/A
N/A
N/A
N/A
-76.3
N/A
N/A
N/A
N/A
Return On Asset
N/A
0.0201
0.0865
-0.0037
-1.9
-0.0892
0.0897
-0.0797
-0.0309
Number Of Shares Shorted
N/A
4.1 M
68.22 M
3 K
N/A
786.13 K
28.73 M
23.24 K
46 K
Book Value Per Share
N/A
2.59
6.24
5.69
-0.08
7.64
1.8
2.54
2.19
Current Liabilities
N/A
N/A
30.14 B
2.26 M
1.33 M
N/A
2.64 M
14 M
37.02 M
Total Asset
N/A
3.77 B
132.64 B
105.71 M
180.81 K
1.03 B
1.54 B
111.87 M
94.19 M
Debt To Equity
N/A
1.96
0.037
0.23
N/A
0.015
0.005
0.32
0.39
Short Ratio
N/A
10.4
2.54
0.48
N/A
1.67
2.89
1.29
1.02
Target Price
N/A
8.66
3.08
N/A
N/A
7.0
41.79
4.0
5.0
Last Dividend Paid
N/A
N/A
0.73
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
96.02
29.48
12.89
N/A
1.11
64.66
21.46
10.59
Market Capitalization
N/A
2.06 B
34.92 B
16.23 M
6.93 K
82.08 M
6.89 B
47.42 M
11.94 M
Price To Earning
N/A
239.0
22.12
13.24
-1.22
N/A
934.36
49.29
50.54
Price To Earnings To Growth
N/A
1.98
1.94
N/A
N/A
N/A
1.41
-0.05
N/A
Price To Sales
N/A
0.76
0.42
0.42
0.0174
0.13
5.03
0.18
0.24
Net Income
N/A
134 K
14.5 B
(1.2 M)
(693.76 K)
(510.37 M)
226.8 M
(63.22 M)
(24.4 M)
Earnings Per Share
N/A
N/A
0.15
-0.6
-0.041
-0.65
0.72
-1.91
-3.3
Shares Owned By Insiders
N/A
4.18
0.02
22.88
N/A
N/A
36.0
56.48
37.98
Revenue
N/A
2.53 B
79.74 B
39.14 M
224.68 K
585.37 M
1.32 B
298.4 M
43.12 M
Working Capital
N/A
(349.26 M)
(4.44 B)
18.4 M
(1.1 M)
624.24 M
928.29 M
29.19 M
(1.42 M)
Cash And Equivalents
N/A
93.4 M
19.06 B
3.13 M
42.61 K
740.97 M
60.03 M
26.4 M
7.19 M
Cash Per Share
N/A
0.71
1.21
0.63
N/A
8.55
0.79
0.33
0.74
Gross Profit
N/A
1.01 B
39.29 B
18.81 M
93.59 K
249.57 M
699.19 M
93.65 M
32.14 M
Day Typical Price
94.18
7.84
2.18
3.31
1.0E-4
0.83
29.35
2.82
1.09
Accumulation Distribution
N/A
0.0139
0.0182
0.003
N/A
0.0706
0.0315
0.0517
0.0446
Market Facilitation Index
N/A
0.11
0.04
0.01
N/A
0.06
0.94
0.15
0.05
Daily Balance Of Power
(9,223,372,036,855)
(0.36)
1.0
(5.00)
0.0
1.0
0.2766
(0.07)
(0.20)
Period Momentum Indicator
(3.35)
(0.04)
0.04
(0.05)
N/A
0.06
0.26
(0.01)
(0.01)
Rate Of Daily Change
0.97
0.99
1.02
0.99
1.0
1.08
1.01
1.0
0.99
Day Median Price
94.18
7.85
2.18
3.31
1.0E-4
0.82
29.37
2.83
1.1
Price Action Indicator
(1.67)
(0.04)
0.03
(0.02)
N/A
0.05
0.07
(0.02)
(0.03)
Relative Strength Index
60.95
8.54
29.65
57.51
N/A
48.49
45.94
37.06
27.42
Coefficient Of Variation
(2,975)
1123.22
(1,848)
(1,322)
N/A
(2,933)
(1,018)
3256.41
(2,097)
Mean Deviation
0.1979
1.92
1.16
1.33
N/A
3.51
2.71
3.6
3.21
Jensen Alpha
(0.02)
(0.03)
(0.12)
(0.12)
N/A
(0.24)
(0.47)
0.1537
(0.32)
Total Risk Alpha
(0.12)
(0.17)
(0.33)
(0.42)
N/A
(0.99)
(0.98)
(0.60)
(0.89)
Sortino Ratio
N/A
0.035
N/A
N/A
N/A
N/A
N/A
0.0031
N/A
Downside Variance
N/A
5.61
N/A
N/A
N/A
N/A
N/A
17.15
N/A
Standard Deviation
0.5611
2.4
1.52
1.76
N/A
5.14
3.81
4.67
4.29
Kurtosis
51.2
0.1607
0.1057
0.8975
N/A
2.87
3.12
0.5832
0.4391
Potential Upside
0.3508
3.76
2.4
3.28
N/A
8.42
5.82
8.58
8.45
Treynor Ratio
0.4826
0.107
(0.39)
0.6764
N/A
(0.40)
(0.56)
(0.80)
(0.24)
Maximum Drawdown
4.69
9.83
6.97
8.49
N/A
26.9
20.47
22.85
21.51
Variance
0.3149
5.76
2.32
3.09
N/A
26.39
14.5
21.82
18.4
Market Risk Adjusted Performance
0.4926
0.117
(0.38)
0.6864
N/A
(0.39)
(0.55)
(0.79)
(0.23)
Risk Adjusted Performance
(0.03)
0.0751
(0.04)
(0.05)
N/A
(0.02)
(0.07)
0.0319
(0.03)
Skewness
(6.70)
0.1565
(0.36)
0.7337
N/A
(0.52)
0.716
0.7388
0.4
Semi Deviation
N/A
2.13
N/A
N/A
N/A
N/A
N/A
3.88
N/A
Information Ratio
(0.27)
0.0345
(0.14)
(0.15)
N/A
(0.06)
(0.13)
0.0027
(0.08)
Value At Risk
(0.21)
(3.72)
(2.69)
(2.87)
N/A
(6.33)
(5.22)
(6.28)
(6.06)
Expected Short fall
N/A
(2.13)
N/A
N/A
N/A
N/A
N/A
(4.10)
N/A
Downside Deviation
N/A
2.37
N/A
N/A
N/A
N/A
N/A
4.14
N/A
Semi Variance
N/A
4.54
N/A
N/A
N/A
N/A
N/A
15.04
N/A

IMBLN Competition Performance Charts

Five steps to successful analysis of IMBLN Competition

IMBLN's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by IMBLN 35 26 in relation to its competition. IMBLN's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of IMBLN in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact IMBLN's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to IMBLN 35 26, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your IMBLN position

In addition to having IMBLN in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in IMBLN Bond

IMBLN financial ratios help investors to determine whether IMBLN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IMBLN with respect to the benefits of owning IMBLN security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY